Silvercrest Asset Management’s NeoGenomics NEO Stock Holding History

Silvercrest Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-262,120	Closed	-$3.19M	–	835
2022 Q1	$3.19M	Buy	262,120 +58,392	+29%	+$1.23M	0.02%	440
2021 Q4	$6.95M	Buy	203,728 +64,733	+47%	+$2.54M	0.04%	325
2021 Q3	$6.71M	Sell	138,995 -1,592	-1%	-$73.7K	0.05%	337
2021 Q2	$6.35M	Buy	140,587 +1,646	+1%	+$72.9K	0.04%	356
2021 Q1	$6.7M	Sell	138,941 -12,126	-8%	-$631K	0.05%	320
2020 Q4	$8.13M	Sell	151,067 -63,558	-30%	-$2.87M	0.06%	276
2020 Q3	$7.92M	Sell	214,625 -50,797	-19%	-$1.89M	0.07%	252
2020 Q2	$8.22M	Buy	265,422 +34,160	+15%	+$947K	0.07%	241
2020 Q1	$6.38M	Sell	231,262 -5,699	-2%	-$171K	0.07%	240
2019 Q4	$6.93M	Buy	236,961 +42,631	+22%	+$1.02M	0.05%	285
2019 Q3	$3.72M	Buy	+194,330	New	+$4.56M	0.03%	398

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Silvercrest Asset Management's NEO Position: Q2 2022 in Review

Silvercrest Asset Management sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 262,120 shares — an estimated $3.19M sold.

Silvercrest Asset Management first reported a position in NEO in Q3 2019 and held it in 11 quarters. The position peaked at $8.22M in Q2 2020. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

Silvercrest Asset Management reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
Silvercrest Asset Management sold 262,120 NeoGenomics shares in Q2 2022, an estimated $3.19M.
Silvercrest Asset Management first reported a position in NeoGenomics in Q3 2019 and held it in 11 quarters.
Silvercrest Asset Management's NeoGenomics position peaked at $8.22M in Q2 2020.
239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Silvercrest Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.